Qubis
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
StimOxyGen
11 Mar 2025
StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy
StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.
More venture news
- 21 May 2026
ImperagenImperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences - 11 May 2026
Scarlet TherapeuticsScarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
SeedLife Sciences - 12 May 2026
White CircleWhite Circle raises £8m from leading industry angels for platform that monitors AI model behaviour
SeedAI
